Patent Yard Sign in
Canadian application, no grantCanada

Method for treating heart failure

CA 2245095 A1 · Owner: Hilton, Christopher John · Inventors: Aurup, Peter; Hilton, Christopher John; Friedrich, Tilman

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a medicine for treating a mammal which presents with heart failure, comprising a therapeutically effective amount of dofetilide or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable vehicle or diluent.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 17, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 17, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 17, 1998
GrantedNo grant recorded
Term endedAugust 17, 2018
Patent numberCA 2245095 A1
Classification (IPC)A61K31/18

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedAug 17, 1998Term endedAug 17, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.